Skip to main content

Industry News

Crack GPAT — Prepare for GPAT Online 
  • Cipla Ltd, a Rs. 10,880 crore plus fifth largest pharma company in India, has launched generic drug ledipasvir-sofosbuvir in India under the brand name Hepcvir-L. Hepcvir- L, the first once-a-day, fixed-dose oral combination therapy that has been approved for chronic hepatitis C genotype 1 patients.

  • The U.S. Food and Drug Administration approved a new indication for the LifeVest wearable cardioverter defibrillator. The LifeVest is approved for certain children who are at risk for sudden cardiac arrest, but are not candidates for an implantable defibrillator due to certain medical conditions or lack of parental consent. The LifeVest defibrillator is manufactured by the ZOLL Manufacturing Corporation based in Pittsburgh, Pennsylvania.

  • Highlights:

    • There will be a separate ministry of Pharmaceuticals & Medical Devices which will be created within one year which will ease the working for the Industry with a single point contact.
    • Katoch Committee Report on the API and Bulk Drugs Policy will be accepted within 100 days
    • Inverted duty issues will be taken up by him personally with the Hon’ble Finance Minister based on the recommendations of PHD Chamber.

    This conference was held in association with Department of Pharmaceuticals, Ministry of Chemical & Fertilizers Government of India. The main objective of the Conference was to promote innovation and boost Pharmaceutical and Medical Devices manufacturing Industry through technology transfer and focus on high value production to provide world class Affordable, Acceptable and Accessible health care products. The Conference created a neutral platform wherein strategies & policy issues were discussed for the growth of the Healthcare industry.

    [adsense:336x280:8701650588]

  • The U.S. Food and Drug Administration  approved Bridion (sugammadex) injection to reverse the effects of neuromuscular blockade induced by rocuronium bromide and vecuronium bromide, which are used during certain types of surgery in adults. Bridion is marketed by Merck Sharp and Dohme Corp., a subsidiary of Merck and Company, Inc., based in Whitehouse Station, New Jersey.

    [adsense:336x280:8701650588]

  • U.S. Department of Justice entered a consent decree of permanent injunction in the District of Vermont against the Correia Family Limited Partnership, doing business as Wynsum Holsteins, a dairy farm located in West Addison, Vermont, and its partners, Anthony Correia, Barbara Correia and Stephen Correia. The decree accompanies a complaint filed at the request of the U.S. Food and Drug Administration.

  • AstraZeneca  announced that it has entered into a definitive agreement to acquire the core respiratory business of Takeda Pharmaceutical Company Limited (“Takeda”). The deal will include the expansion of rights to roflumilast (marketed as Daliresp in the US and Daxas in other countries), the only approved oral PDE4 inhibitor for the treatment of chronic obstructive pulmonary disease (COPD).

Subscribe to Industry News